Article
Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells.
Cancer immunology, immunotherapy : CII - 1 Apr 2003
Itoh Tsuyoshi, Ueda Yuji, Okugawa Kaori, Fujiwara Hitoshi, Fuji Nobuaki, Yamashita Tetsuro, Fujiki Hiroshi, Harada Sachio, Yoshimura Tetsunori, Yamagishi Hisakazu
Abstract excerpt
Streptococcal preparation OK432 is an immunomodulatory agent extensively used as adjuvant therapy for gastric cancer in Japan. OK432 augments the cytotoxic activity of various effector cells such as lymphocytes, macrophages and (natural killer) NK cells and induces the production of multiple cytokines. Dendritic cells (DC) are professional antigen-presenting cells (APC) that can be used for cancer vaccine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
